| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.55 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.27 | 0.05 |